AI-powered chatbots, such as OpenAI’s ChatGPT, have the potential to transform the healthcare industry. The technology has advanced faster than expected, and the AI market is expected to be worth USD 383.3 billion by 2030, with a compound annual growth rate of 21% from 2022 to 2030. Chatbots have several social purposes in healthcare, including increasing patient engagement, offering advice on how to maintain health after treatment, and sending automated reminders to take medications. In a recent study, ChatGPT was found 97% accurate in providing the correct information about cancer, indicating the technology’s potential to assist patients with accurate information. However, the use of chatbots in patient care and medical research raises ethical concerns, such as the vulnerability of patient information fed into machine learning. Despite the risks, AI-powered chatbots are expected to be widely used in the healthcare industry, and further regulations are expected to govern their use.
OpenAI’s ChatGPT: A Revolutionary Technology for Healthcare
New research has emerged that OpenAI’s ChatGPT, a chatbot capable of writing original prose and interacting with human fluency, has the potential to transform the healthcare industry. The report by GlobalData, a data and analytics company, states that the technology is advancing faster than most people in the industry expected.
According to the report, the artificial intelligence (AI) market is expected to be worth USD 383.3 billion by 2030, with a compound annual growth rate (CAGR) of 21% from 2022 to 2030. The integration of AI into chatbots and virtual assistants has the potential to improve patient interaction, increase the accuracy of processes for preventive care, symptom identification, and post-recovery care.
Tina Deng, Principal Medical Devices Analyst at GlobalData, said in an official statement that ChatGPT can help doctors with bureaucratic tasks such as writing patient letters, enabling them to spend more time with patients. Additionally, AI-enabled chatbots can recommend diagnostic advice based on patient symptoms and suggest options such as virtual check-ins or face-to-face visits with a healthcare professional.
During the COVID-19 pandemic, chatbots were developed for contactless screening of COVID-19 symptoms in healthcare institutions and to help doctors answer questions from the public. Pharmaceutical and medical device companies can also benefit from using AI-enabled virtual agents to automate customer service processes, providing round-the-clock attention to patients.
Chatbots can not only reduce the workload for hospital staff but also increase the efficiency of patient flow, leading to significant healthcare cost savings. Moreover, chatbots can answer patients’ queries about medical products and share brand news with customers.
In conclusion, OpenAI’s ChatGPT is a revolutionary technology that has the potential to transform the healthcare industry. With its ability to write original prose and interact with human fluency, it can help doctors with bureaucratic tasks and improve patient interaction while reducing healthcare costs.
AI-powered Chatbots can help patients with accurate information about cancer
AI-powered chatbots offer a wide range of social purposes in healthcare. They can increase patient engagement by offering advice on how to maintain health after treatment, sending automated reminders to take medications, and revisiting information. In a recent study, ChatGPT has been found 97% accurate in providing correct information regarding cancer. Test subjects were unable to differentiate whether the information was provided by ChatGPT or the National Cancer Institute. However, the usage of chatbots in patient care and medical research raises ethical concerns, such as patient information being vulnerable as it is fed into machine learning. Despite the risks, AI-powered chatbots are expected to be widely used in the healthcare industry, and further regulations are expected to govern their use.
Don’t miss interesting posts on Famousbio
